LPCH/Stanford — Palo Alto, California

LPCH/Stanford is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

LPCH/Stanford has participated in 1 clinical trials.

Therapeutic areas: Lymphoid Malignancies, Lymphoproliferative Disorders.

Sponsors: HemaQuest Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for LPCH/Stanford?

LPCH/Stanford has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has LPCH/Stanford conducted?

LPCH/Stanford has 1 clinical trials on record. Their work covers Lymphoid Malignancies, Lymphoproliferative Disorders.

Is LPCH/Stanford accredited by Crixeo Health?

LPCH/Stanford has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about LPCH/Stanford?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.